Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Karuna Therapeutics, Inc. (KRTX)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 40,277,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Karuna Therapeutics is a clinical-stage biopharmaceutical company that focuses on transformative medicines for people living with psychiatric and neurological conditions. Co.'s proprietary product candidate, KarXT (xanomeline-trospium), an oral modulator of muscarinic receptors that are located both in the central nervous system (CNS) and various peripheral tissues. KarXT combines xanomeline, a muscarinic agonist, with trospium, an approved muscarinic antagonist, to preferentially stimulate muscarinic receptors in the CNS. Co. is developing KarXT for the treatment of psychosis in adults with schizophrenia as well as for the treatment of psychosis in Alzheimer's disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 120,000
Total Buy Value $0 $0 $0 $14,736,159
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 2
Total Shares Sold 10,000 40,000 107,929 348,973
Total Sell Value $3,172,380 $10,837,466 $24,302,893 $74,283,009
Total People Sold 1 1 4 6
Total Sell Transactions 2 5 14 44
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 160
  Page 1 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Healy James Director   –       •      –    2022-06-30 4 B $122.27 $8,857,767 I/I 72,223 2,072,441 2.1     -
   Healy James Director   –       •      –    2022-06-29 4 B $121.99 $5,878,392 I/I 47,777 2,000,218 2.1     -
   Paul Steven M CSO and President of R&D   •       •      –    2022-05-31 4 GA $0.00 $0 I/I 106,485 106,485     -
   Paul Steven M CSO and President of R&D   •       •      –    2022-05-31 4 GD $0.00 $0 I/I 106,485 0     -
   Paul Steven M CSO and President of R&D   •       •      –    2022-05-27 4 GA $0.00 $0 I/I 106,485 106,485     -
   Paul Steven M CSO and President of R&D   •       •      –    2022-05-27 4 GD $0.00 $0 I/I 106,485 0     -
   Olson Laurie J   –       •      –    2022-05-27 4 AS $110.00 $110,000 D/D (1,000) 0     -
   Olson Laurie J   –       •      –    2022-05-27 4 OE $84.86 $84,860 D/D 1,000 1,000     -
   Brannan Stephen K. Chief Medical Officer   •       –      –    2022-05-09 4 AS $104.10 $520,500 D/D (5,000) 15,000     -
   Brannan Stephen K. Chief Medical Officer   •       –      –    2022-05-09 4 OE $9.20 $46,000 D/D 5,000 20,000     -
   Ignelzi Troy A. Chief Financial Officer   •       –      –    2022-04-21 4 AS $134.46 $5,378 D/D (40) 24,970     -
   Ignelzi Troy A. Chief Financial Officer   •       –      –    2022-04-21 4 OE $9.20 $368 D/D 40 25,010     -
   Ignelzi Troy A. Chief Financial Officer   •       –      –    2022-04-20 4 AS $133.20 $93,773 D/D (704) 24,970     -
   Ignelzi Troy A. Chief Financial Officer   •       –      –    2022-04-20 4 OE $9.20 $6,477 D/D 704 25,674     -
   Ignelzi Troy A. Chief Financial Officer   •       –      –    2022-04-19 4 AS $130.81 $457,835 D/D (3,500) 24,970     -
   Ignelzi Troy A. Chief Financial Officer   •       –      –    2022-04-19 4 OE $9.20 $32,200 D/D 3,500 28,470     -
   Healy James Director   –       •      –    2022-04-01 4 B $129.38 $6,081 I/I 47 683 2.1     -
   Brannan Stephen K. Chief Medical Officer   •       –      –    2022-04-01 4 AS $128.45 $992,662 D/D (7,728) 15,000     -
   Brannan Stephen K. Chief Medical Officer   •       –      –    2022-04-01 4 OE $5.45 $69,808 D/D 10,228 22,728     -
   Brannan Stephen K. Chief Medical Officer   •       –      –    2022-03-01 4 AS $107.38 $829,833 D/D (7,728) 12,500     -
   Brannan Stephen K. Chief Medical Officer   •       –      –    2022-03-01 4 OE $5.45 $84,723 D/D 10,228 20,228     -
   Olson Laurie J   –       •      –    2022-02-15 4 AS $110.00 $110,000 D/D (1,000) 0     -
   Olson Laurie J   –       •      –    2022-02-15 4 OE $84.86 $84,860 D/D 1,000 1,000     -
   Ignelzi Troy A. Chief Financial Officer   •       –      –    2022-02-15 4 AS $111.14 $166,710 D/D (1,500) 24,970     -
   Ignelzi Troy A. Chief Financial Officer   •       –      –    2022-02-15 4 OE $9.20 $13,800 D/D 1,500 26,470     -
  160 Records found
  1  2  3  4  5  6  7   
  Page 1 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us